T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.42B |
| 2 |
Wynn Resorts
WYNN
|
+$992M |
| 3 |
Eli Lilly
LLY
|
+$964M |
| 4 |
Visa
V
|
+$700M |
| 5 |
American Airlines Group
AAL
|
+$626M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$1.24B |
| 2 |
Dollar Tree
DLTR
|
+$1.13B |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$1.03B |
| 4 |
Gilead Sciences
GILD
|
+$792M |
| 5 |
ROC
ROCKWOOD HLDGS INC
ROC
|
+$788M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.45% |
| 2 | Consumer Discretionary | 13.78% |
| 3 | Financials | 12.98% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Allegion
ALLE
$14.2B
| $6.81M | ﹤0.01% |
142,884
+4,300
| +3% | +$225K |
|
1402
BHP
BHP
$222B
| $6.74M | ﹤0.01% |
135,414
+21,288
| +19% | +$1.24M |
|
|
AIG.WS
1403
DELISTED
American International Group, Inc.
AIG.WS
| $6.73M | ﹤0.01% |
281,700
-87,000
| -24% | -$2.2M |
|
1404
Designer Brands
DBI
$312M
| $6.72M | ﹤0.01% |
223,062
-1,090,400
| -83% | -$31.3M |
|
|
AVDL
1405
DELISTED
Avadel Pharmaceuticals
AVDL
| $6.61M | ﹤0.01% |
+462,100
| New | +$6.64M |
|
1406
TriplePoint Venture Growth BDC
TPVG
$221M
| $6.47M | ﹤0.01% |
442,900
+8,300
| +2% | +$128K |
|
|
CTRX
1407
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $6.43M | ﹤0.01% |
152,538
-1,243,669
| -89% | -$56.5M |
|
|
CYBR
1408
DELISTED
CyberArk
CYBR
| $6.4M | ﹤0.01% |
+200,000
| New | +$6.02M |
|
|
SRT
1409
DELISTED
Startek Inc.
SRT
| $6.38M | ﹤0.01% |
824,530
| – | – |
|
|
TE
1410
DELISTED
TECO ENERGY INC
TE
| $6.38M | ﹤0.01% |
367,165
+16,200
| +5% | +$287K |
|
1411
Cousins Properties
CUZ
$4.93B
| $6.38M | ﹤0.01% |
189,145
-298,200
| -61% | -$10.6M |
|
|
PDCO
1412
DELISTED
Patterson Companies, Inc.
PDCO
| $6.28M | ﹤0.01% |
151,660
-10
| -0% | -$399 |
|
|
ISIL
1413
DELISTED
Intersil Corp
ISIL
| $6.28M | ﹤0.01% |
441,952
+383,440
| +655% | +$5.57M |
|
|
BMS
1414
DELISTED
Bemis
BMS
| $6.23M | ﹤0.01% |
163,784
| – | – |
|
1415
Innoviva
INVA
$1.5B
| $6.22M | ﹤0.01% |
364,194
+848
| +0.2% | +$19.5K |
|
|
GLOP
1416
DELISTED
GASLOG PARTNERS LP
GLOP
| $6.2M | ﹤0.01% |
202,000
+2,000
| +1% | +$65.3K |
|
|
NAUH
1417
DELISTED
National American University Holdings, Inc.
NAUH
| $6.19M | ﹤0.01% |
2,024,143
+800
| +0% | +$2.5K |
|
1418
XPO
XPO
$24.7B
| $6.17M | ﹤0.01% |
473,746
-5,494
| -1% | -$60K |
|
1419
Jabil
JBL
$38.8B
| $6.13M | ﹤0.01% |
304,113
-3,300
| -1% | -$69K |
|
1420
Exponent
EXPO
$3.24B
| $6.07M | ﹤0.01% |
342,416
+14,800
| +5% | +$272K |
|
1421
Ulta Beauty
ULTA
$22.2B
| $5.94M | ﹤0.01% |
50,276
+109
| +0.2% | +$10.8K |
|
|
PPLI
1422
People Inc
PPLI
$3.01B
| $5.94M | ﹤0.01% |
504,253
+379,475
| +304% | +$4.59M |
|
1423
Buckle
BKE
$2.31B
| $5.93M | ﹤0.01% |
130,762
+1,800
| +1% | +$83.1K |
|
1424
Pegasystems
PEGA
$5.51B
| $5.87M | ﹤0.01% |
614,600
+116,200
| +23% | +$1.25M |
|
|
DISH
1425
DELISTED
DISH Network Corp.
DISH
| $5.82M | ﹤0.01% |
90,143
+4,818
| +6% | +$311K |
|
Similar funds
T. Rowe Price Associates's Q3 2014 Portfolio in Review
As of Q3 2014, T. Rowe Price Associates held 2,614 positions worth $458B, down 1% from $463B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q3 2014 filing shows 88 new, 949 increased, 837 reduced and 73 closed positions. Its largest new stake was Alibaba: 26,922,443 shares worth $2.39B. The largest sale was PepsiCo, an estimated $1.24B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2014 buy was Alibaba: 26,922,443 shares worth $2.39B.
- T. Rowe Price Associates added most to Wynn Resorts in Q3 2014, an estimated $992M increase.
- T. Rowe Price Associates's biggest Q3 2014 reduction was PepsiCo, cutting an estimated $1.24B.
- T. Rowe Price Associates fully exited ROCKWOOD HLDGS INC in Q3 2014, selling an estimated $788M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $458B portfolio in Q3 2014.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2014.
- T. Rowe Price Associates's portfolio value fell 1% quarter-over-quarter to $458B.
Based on T. Rowe Price Associates's 13F filing for Q3 2014, filed 14 Nov 2014.